This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Apr 15;160(8):JC6.

doi: 10.7326/0003-4819-160-8-201404150-02006.

ACP Journal Club. 4F-PCC was noninferior to plasma in patients with acute major bleeding who needed urgent VKA reversal

PMID: 24733223
DOI: 10.7326/0003-4819-160-8-201404150-02006

Comment

ACP Journal Club. 4F-PCC was noninferior to plasma in patients with acute major bleeding who needed urgent VKA reversal

Eddy Lang. Ann Intern Med. 2014.

. 2014 Apr 15;160(8):JC6.

doi: 10.7326/0003-4819-160-8-201404150-02006.

Author

PMID: 24733223
DOI: 10.7326/0003-4819-160-8-201404150-02006

No abstract available

PubMed Disclaimer

Comment on

Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.
Sarode R, Milling TJ Jr, Refaai MA, Mangione A, Schneider A, Durn BL, Goldstein JN. Sarode R, et al. Circulation. 2013 Sep 10;128(11):1234-43. doi: 10.1161/CIRCULATIONAHA.113.002283. Epub 2013 Aug 9. Circulation. 2013. PMID: 23935011 Free PMC article. Clinical Trial.

Similar articles

Four-factor prothrombin complex concentrate for urgent reversal of vitamin K antagonists in patients with major bleeding.
Quinlan DJ, Eikelboom JW, Weitz JI. Quinlan DJ, et al. Circulation. 2013 Sep 10;128(11):1179-81. doi: 10.1161/CIRCULATIONAHA.113.005107. Epub 2013 Aug 9. Circulation. 2013. PMID: 23935012 No abstract available.
Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study.
Sarode R, Milling TJ Jr, Refaai MA, Mangione A, Schneider A, Durn BL, Goldstein JN. Sarode R, et al. Circulation. 2013 Sep 10;128(11):1234-43. doi: 10.1161/CIRCULATIONAHA.113.002283. Epub 2013 Aug 9. Circulation. 2013. PMID: 23935011 Free PMC article. Clinical Trial.
Emergent reversal of vitamin K antagonists: addressing all the factors.
Martin DT, Barton CA, Dodgion C, Schreiber M. Martin DT, et al. Am J Surg. 2016 May;211(5):919-25. doi: 10.1016/j.amjsurg.2016.02.007. Epub 2016 Mar 10. Am J Surg. 2016. PMID: 27046797
Prothrombin complex concentrates as reversal agents for new oral anticoagulants: lessons from preclinical studies with Beriplex.
Dickneite G. Dickneite G. Clin Lab Med. 2014 Sep;34(3):623-35. doi: 10.1016/j.cll.2014.06.001. Epub 2014 Jul 18. Clin Lab Med. 2014. PMID: 25168947 Review.
Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal: Does One Dose Fit All?
Schwebach AA, Waybright RA, Johnson TJ. Schwebach AA, et al. Pharmacotherapy. 2019 May;39(5):599-608. doi: 10.1002/phar.2261. Epub 2019 Apr 21. Pharmacotherapy. 2019. PMID: 30892733 Review.

See all similar articles

Cited by

Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia.
Fabes J, Brunskill SJ, Curry N, Doree C, Stanworth SJ. Fabes J, et al. Cochrane Database Syst Rev. 2018 Dec 24;12(12):CD010649. doi: 10.1002/14651858.CD010649.pub2. Cochrane Database Syst Rev. 2018. PMID: 30582172 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information